Beam Therapeutics Inc is trading 4% down at $29.89 as investors take profits following a recent 20% rally.
- The stock is experiencing a pullback after a sharp run-up in late May and early June that saw gains of over 20% in just a few sessions.
- There are no new company-specific developments or analyst calls today; the move is attributed to profit-taking and normal high-beta biotech volatility.